• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Improved outcome in heart failure.

作者信息

Armstrong P W

机构信息

University of Alberta, Edmonton, Canada.

出版信息

Int J Clin Pract Suppl. 1999 Apr;100:10-1.

PMID:10658291
Abstract
摘要

相似文献

1
Improved outcome in heart failure.心力衰竭治疗效果的改善
Int J Clin Pract Suppl. 1999 Apr;100:10-1.
2
Effect of angiotensin-converting enzyme inhibition on functional class in patients with left ventricular systolic dysfunction--a meta-analysis.血管紧张素转换酶抑制对左心室收缩功能不全患者心功能分级的影响——一项荟萃分析。
Eur J Heart Fail. 2006 Jan;8(1):90-6. doi: 10.1016/j.ejheart.2005.03.006. Epub 2005 Jul 27.
3
Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.组织血管紧张素转换酶抑制剂用于预防无左心室收缩功能障碍或心力衰竭临床证据的糖尿病患者心血管疾病：随机安慰剂对照临床试验的汇总荟萃分析
Diabetes Obes Metab. 2008 Jan;10(1):41-52. doi: 10.1111/j.1463-1326.2006.00688.x.
4
Asymptomatic left ventricular dysfunction: to treat or not to treat?无症状左心室功能障碍：治疗还是不治疗？
J Heart Lung Transplant. 1994 Jul-Aug;13(4):S135-40.
5
A meta-analysis of the effect of angiotensin-converting enzyme inhibitors on functional capacity in patients with symptomatic left ventricular systolic dysfunction.
Eur J Heart Fail. 2004 Dec;6(7):927-35. doi: 10.1016/j.ejheart.2004.02.002.
6
Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?在慢性心力衰竭和急性心肌梗死中应使用哪种肾素-血管紧张素系统抑制剂？
Circulation. 2004 Nov 16;110(20):3281-8. doi: 10.1161/01.CIR.0000147274.83071.68.
7
Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.冠心病且无心力衰竭或左心室收缩功能障碍患者使用血管紧张素转换酶抑制剂：长期随机对照试验综述
Arch Intern Med. 2006 Apr 10;166(7):787-96. doi: 10.1001/archinte.166.7.787.
8
The pharmacological treatment of heart failure: are we looking at the sunset of the neurohormonal hypothesis.心力衰竭的药物治疗：我们是否正目睹神经激素假说的落幕？
Ital Heart J. 2002 Jul;3(7):437-8.
9
The relevance of subgroup-specific treatment effects: the Studies Of Left Ventricular Dysfunction (SOLVD) revisited.亚组特异性治疗效果的相关性：对左心室功能障碍研究（SOLVD）的重新审视。
Am Heart J. 2002 Dec;144(6):941-7. doi: 10.1067/mhj.2002.126446.
10
Letter regarding article by Masoudi et al, "national patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction".
Circulation. 2005 May 3;111(17):e276-7; author reply e276-7. doi: 10.1161/01.CIR.0000163540.84871.16.

引用本文的文献

1
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.β受体阻滞剂和肾素-血管紧张素-醛固酮系统抑制剂用于射血分数保留的慢性心力衰竭。
Cochrane Database Syst Rev. 2021 May 22;5(5):CD012721. doi: 10.1002/14651858.CD012721.pub3.
2
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.用于射血分数保留的慢性心力衰竭的β受体阻滞剂和肾素-血管紧张素-醛固酮系统抑制剂。
Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD012721. doi: 10.1002/14651858.CD012721.pub2.